USFDA completes Strides’ facility inspection in Bangalore

Strides Shasun announced successful completion of USFDA inspection at its flagship Oral Dosage Facility in Bangalore with ‘Zero 483s


(Photo Courtesy:

The company is a vertically integrated global pharmaceutical company headquartered in Bangalore.

The audit was carried out related to a product filed from the new, semi-solids block from where the company has made a series of filings.

With the recently closed Establishment Inspection Report (EIR) announced on June 7, 2016, the entire facility is now USFDA compliant.

The Oral Dosage facility in Bangalore manufactures oral dosage forms including tablets, capsules (both hard and soft gelatine), ointments and liquids.

The manufacturing plant supports important current and future submissions for the US market.


Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email